{"doi":"10.1001/jamaneurol.2013.123","field":"神経科学・行動科学","meta":{"pageid":"24943243","title":"Parkinson's Disease Foundation","anonymous":false,"userid":"11069646","username":"Gnusworthy","type":"user","revid":"551501806","comment":"Added current research highlights and examples of clinical research advocacy","timestamp":"2013-04-21T19:23:21Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.123","doi_suffix":"jamaneurol.2013.123","pubmed":["23479138"],"pmc":["3791511"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2013.123","doi_suffix":"jamaneurol.2013.123"},"meta":{"anonymous":false,"userid":"11069646","username":"Gnusworthy","revid":"551501806","comment":"Added current research highlights and examples of clinical research advocacy","timestamp":"2013-04-21T19:23:21Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"randomized controlled clinical trial of “virtual house calls” for parkinson disease","doi_title_full_normalized":"randomized controlled clinical trial of virtual house calls for parkinson disease","doi_title_full_normalized_without_spc":"randomizedcontrolledclinicaltrialofvirtualhousecallsforparkinsondisease","doi_title_first_words":"randomized controlled clinical trial of","doi_title_first_words_normalized":"randomized controlled clinical trial of","doi_title_first_words_nomralized_without_spc":"randomizedcontrolledclinicaltrialof","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":false,"userid":"11069646","username":"Gnusworthy","revid":"551501806","comment":"Added current research highlights and examples of clinical research advocacy","timestamp":"2013-04-21T19:23:21Z"}},"MethodC":{"cond_score":0.2,"wikitext":{"original":"<ref>{{cite journal|last=Dorsey|first=E. Ray|coauthors=Venkataraman V, Grana MJ, Bull MT, George BP, Boyd CM, Beck CA, Rajan B, Seidmann A, Biglan KM|title=Randomized Controlled Clinical Trial of “Virtual House Calls” for Parkinson Disease|journal=JAMA Neurology|date=11|year=2013|month=March|doi=10.1001/jamaneurol.2013.123|url=http://archneur.jamanetwork.com/article.aspx?articleid=1663362|accessdate=21 April 2013}}</ref>","ref_title":"Randomized Controlled Clinical Trial of “Virtual House Calls” for Parkinson Disease","ref_title_normalized":"randomizedcontrolledclinicaltrialofvirtualhousecallsforparkinsondisease"},"meta":{"anonymous":false,"userid":"11069646","username":"Gnusworthy","revid":"551501806","comment":"Added current research highlights and examples of clinical research advocacy","timestamp":"2013-04-21T19:23:21Z"},"doi_title":"randomized controlled clinical trial of “virtual house calls” for parkinson disease","doi_title_normalized":"randomizedcontrolledclinicaltrialofvirtualhousecallsforparkinsondisease","title_length":71,"levenshtein_distance":0,"score_similarity":0.0}}
{"doi":"10.1001/jamaneurol.2013.3499","field":"神経科学・行動科学","meta":{"pageid":"1592325","title":"Glutamate decarboxylase","anonymous":true,"username":"24.90.6.255","type":"ip","revid":"744870672","comment":"/* Role in pathology */","timestamp":"2016-10-17T23:05:23Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.3499","doi_suffix":"jamaneurol.2013.3499","pubmed":["23877118"],"pmc":["6055982"]},"matched_identifiers":{"pubmed":["23877118"]},"meta":{"anonymous":true,"username":"24.90.6.255","revid":"744870672","comment":"/* Role in pathology */","timestamp":"2016-10-17T23:05:23Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","doi_title_full_normalized":"neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","doi_title_full_normalized_without_spc":"neuronalsurfaceandglutamicaciddecarboxylaseautoantibodiesinnonparaneoplasticstiffpersonsyndrome","doi_title_first_words":"neuronal surface and glutamic acid","doi_title_first_words_normalized":"neuronal surface and glutamic acid","doi_title_first_words_nomralized_without_spc":"neuronalsurfaceandglutamicacid","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":true,"username":"2604:2000:800E:6D00:D553:2C73:F656:323C","revid":"744872082","comment":"/* Stiff Person Syndrome */","timestamp":"2016-10-17T23:19:19Z"}},"MethodC":{"cond_score":0.2,"wikitext":{"original":"<ref>{{cite journal|last1=Chang|first1=T|title=Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome |journal=JAMA Neurology|date=2013 Sep 1|volume=70|issue=9|page=1140-9|url=https://www.ncbi.nlm.nih.gov/pubmed/23877118|accessdate=17 October 2016|ref=PMID: 23877118}}</ref>","ref_title":"Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome","ref_title_normalized":"neuronalsurfaceandglutamicaciddecarboxylaseautoantibodiesinnonparaneoplasticstiffpersonsyndrome"},"meta":{"anonymous":true,"username":"2604:2000:800E:6D00:D553:2C73:F656:323C","revid":"744872082","comment":"/* Stiff Person Syndrome */","timestamp":"2016-10-17T23:19:19Z"},"doi_title":"neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome","doi_title_normalized":"neuronalsurfaceandglutamicaciddecarboxylaseautoantibodiesinnonparaneoplasticstiffpersonsyndrome","title_length":95,"levenshtein_distance":0,"score_similarity":0.0}}
{"doi":"10.1001/jamaneurol.2013.3545","field":"神経科学・行動科学","meta":{"pageid":"18914017","title":"Alzheimer's disease","anonymous":false,"userid":"557657","username":"George Church","type":"user","revid":"575106181","comment":"updated genetics and mechanisms organization","timestamp":"2013-09-30T07:09:47Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.3545","doi_suffix":"jamaneurol.2013.3545","pubmed":["23978990"],"pmc":["3991012"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2013.3545","doi_suffix":"jamaneurol.2013.3545","pubmed":["23978990"]},"meta":{"anonymous":false,"userid":"557657","username":"George Church","revid":"575106181","comment":"updated genetics and mechanisms organization","timestamp":"2013-09-30T07:09:47Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"evidence of recessive alzheimer disease loci in a caribbean hispanic data set","doi_title_full_normalized":"evidence of recessive alzheimer disease loci in a caribbean hispanic data set","doi_title_full_normalized_without_spc":"evidenceofrecessivealzheimerdiseaselociinacaribbeanhispanicdataset","doi_title_first_words":"evidence of recessive alzheimer disease","doi_title_first_words_normalized":"evidence of recessive alzheimer disease","doi_title_first_words_nomralized_without_spc":"evidenceofrecessivealzheimerdisease","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":false,"userid":"557657","username":"George Church","revid":"575106181","comment":"updated genetics and mechanisms organization","timestamp":"2013-09-30T07:09:47Z"}},"MethodC":{"cond_score":0.2}}
{"doi":"10.1001/jamaneurol.2013.3646","field":"神経科学・行動科学","meta":{"pageid":"3724035","title":"DiGeorge syndrome","anonymous":false,"userid":"1925080","username":"Sarahj2107","type":"user","revid":"690128008","comment":"copy edit, more info, added refs, rm unsourced content","timestamp":"2015-11-11T13:46:24Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.3646","doi_suffix":"jamaneurol.2013.3646","pubmed":["24018986"],"pmc":["4464823"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2013.3646","doi_suffix":"jamaneurol.2013.3646","pubmed":["24018986"],"pmc":["4464823"]},"meta":{"anonymous":false,"userid":"1925080","username":"Sarahj2107","revid":"690128008","comment":"copy edit, more info, added refs, rm unsourced content","timestamp":"2015-11-11T13:46:24Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"association between early-onset parkinson disease and 22q11.2 deletion syndrome","doi_title_full_normalized":"association between early onset parkinson disease and 22q11 2 deletion syndrome","doi_title_full_normalized_without_spc":"associationbetweenearlyonsetparkinsondiseaseand22q112deletionsyndrome","doi_title_first_words":"association between early-onset parkinson disease","doi_title_first_words_normalized":"association between early onset parkinson disease","doi_title_first_words_nomralized_without_spc":"associationbetweenearlyonsetparkinsondisease","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":false,"userid":"1925080","username":"Sarahj2107","revid":"690128008","comment":"copy edit, more info, added refs, rm unsourced content","timestamp":"2015-11-11T13:46:24Z"}},"MethodC":{"cond_score":0.2}}
{"doi":"10.1001/jamaneurol.2013.5857","field":"神経科学・行動科学","meta":{"pageid":"1273094","title":"Neuromyelitis optica","anonymous":true,"username":"80.30.184.198","type":"ip","revid":"663853285","comment":"conus medullaris involvement and anti-mog","timestamp":"2015-05-24T20:50:52Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.5857","doi_suffix":"jamaneurol.2013.5857","pubmed":["24425068"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2013.5857","doi_suffix":"jamaneurol.2013.5857"},"meta":{"anonymous":true,"username":"80.30.184.198","revid":"663853285","comment":"conus medullaris involvement and anti-mog","timestamp":"2015-05-24T20:50:52Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies","doi_title_full_normalized":"neuromyelitis optica spectrum disorders with aquaporin 4 and myelin oligodendrocyte glycoprotein antibodies","doi_title_full_normalized_without_spc":"neuromyelitisopticaspectrumdisorderswithaquaporin4andmyelinoligodendrocyteglycoproteinantibodies","doi_title_first_words":"neuromyelitis optica spectrum disorders with","doi_title_first_words_normalized":"neuromyelitis optica spectrum disorders with","doi_title_first_words_nomralized_without_spc":"neuromyelitisopticaspectrumdisorderswith","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":true,"username":"80.30.184.198","revid":"663853285","comment":"conus medullaris involvement and anti-mog","timestamp":"2015-05-24T20:50:52Z"}},"MethodC":{"cond_score":0.2,"wikitext":{"original":"<ref>Joanna Kitley et al. Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies. A Comparative Study. JAMA Neurol. 2014;71(3):276-283. doi:10.1001/jamaneurol.2013.5857</ref>","input_parscit":"Joanna Kitley et al. Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies. A Comparative Study. JAMA Neurol. 2014;71(3):276-283. doi:10.1001/jamaneurol.2013.5857","ref_title":"Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies. A Comparative Study.","ref_title_normalized":"neuromyelitisopticaspectrumdisorderswithaquaporin4andmyelinoligodendrocyteglycoproteinantibodiesacomparativestudy"},"meta":{"anonymous":true,"username":"80.30.184.198","revid":"663853285","comment":"conus medullaris involvement and anti-mog","timestamp":"2015-05-24T20:50:52Z"},"doi_title":"neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies","doi_title_normalized":"neuromyelitisopticaspectrumdisorderswithaquaporin4andmyelinoligodendrocyteglycoproteinantibodies","title_length":113,"levenshtein_distance":17,"score_similarity":0.1504424778761062}}
{"doi":"10.1001/jamaneurol.2013.592","field":"神経科学・行動科学","meta":{"pageid":"41446547","title":"Autoimmune encephalitis","anonymous":false,"userid":"12259473","username":"Drpsdeb","type":"user","revid":"704427164","comment":"AAANS added","timestamp":"2016-02-11T15:05:37Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.592","doi_suffix":"jamaneurol.2013.592","pubmed":["23407760"],"pmc":["3895328"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2013.592","doi_suffix":"jamaneurol.2013.592","pubmed":["23407760"],"pmc":["3895328"]},"meta":{"anonymous":false,"userid":"12259473","username":"Drpsdeb","revid":"704427164","comment":"AAANS added","timestamp":"2016-02-11T15:05:37Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"insights from lgi1 and caspr2 potassium channel complex autoantibody subtyping","doi_title_full_normalized":"insights from lgi1 and caspr2 potassium channel complex autoantibody subtyping","doi_title_full_normalized_without_spc":"insightsfromlgi1andcaspr2potassiumchannelcomplexautoantibodysubtyping","doi_title_first_words":"insights from lgi1 and caspr2","doi_title_first_words_normalized":"insights from lgi1 and caspr2","doi_title_first_words_nomralized_without_spc":"insightsfromlgi1andcaspr2","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":false,"userid":"12259473","username":"Drpsdeb","revid":"704427164","comment":"AAANS added","timestamp":"2016-02-11T15:05:37Z"}},"MethodC":{"cond_score":0.2,"wikitext":{"original":"<ref>{{Cite journal|title = Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping|url = http://www.ncbi.nlm.nih.gov/pubmed/23407760|journal = JAMA neurology|date = 2013-02-01|issn = 2168-6157|pmc = 3895328|pmid = 23407760|pages = 229–234|volume = 70|issue = 2|doi = 10.1001/jamaneurol.2013.592|first = Christopher J.|last = Klein|first2 = Vanda A.|last2 = Lennon|first3 = Paula A.|last3 = Aston|first4 = Andrew|last4 = McKeon|first5 = Orna|last5 = O'Toole|first6 = Amy|last6 = Quek|first7 = Sean J.|last7 = Pittock}}</ref>","ref_title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","ref_title_normalized":"insightsfromlgi1andcaspr2potassiumchannelcomplexautoantibodysubtyping"},"meta":{"anonymous":false,"userid":"12259473","username":"Drpsdeb","revid":"704427164","comment":"AAANS added","timestamp":"2016-02-11T15:05:37Z"},"doi_title":"insights from lgi1 and caspr2 potassium channel complex autoantibody subtyping","doi_title_normalized":"insightsfromlgi1andcaspr2potassiumchannelcomplexautoantibodysubtyping","title_length":69,"levenshtein_distance":0,"score_similarity":0.0}}
{"doi":"10.1001/jamaneurol.2013.592","field":"神経科学・行動科学","meta":{"pageid":"48174194","title":"Anti-VGKC-complex encephalitis","anonymous":false,"userid":"2083469","username":"Toddiloddi","type":"user","revid":"685287867","comment":null,"timestamp":"2015-10-12T00:31:54Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.592","doi_suffix":"jamaneurol.2013.592","pubmed":["23407760"],"pmc":["3895328"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2013.592","doi_suffix":"jamaneurol.2013.592","pubmed":["23407760"],"pmc":["3895328"]},"meta":{"anonymous":false,"userid":"2083469","username":"Toddiloddi","revid":"685287867","comment":null,"timestamp":"2015-10-12T00:31:54Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"insights from lgi1 and caspr2 potassium channel complex autoantibody subtyping","doi_title_full_normalized":"insights from lgi1 and caspr2 potassium channel complex autoantibody subtyping","doi_title_full_normalized_without_spc":"insightsfromlgi1andcaspr2potassiumchannelcomplexautoantibodysubtyping","doi_title_first_words":"insights from lgi1 and caspr2","doi_title_first_words_normalized":"insights from lgi1 and caspr2","doi_title_first_words_nomralized_without_spc":"insightsfromlgi1andcaspr2","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":false,"userid":"2083469","username":"Toddiloddi","revid":"685287867","comment":null,"timestamp":"2015-10-12T00:31:54Z"}},"MethodC":{"cond_score":0.2,"wikitext":{"original":"<ref name=\"pmid23407760\">{{cite journal| author=Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A et al.| title=Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. | journal=JAMA Neurol | year= 2013 | volume= 70 | issue= 2 | pages= 229-34 | pmid=23407760 | doi=10.1001/jamaneurol.2013.592 | pmc=PMC3895328 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23407760 }} </ref>","ref_title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.","ref_title_normalized":"insightsfromlgi1andcaspr2potassiumchannelcomplexautoantibodysubtyping"},"meta":{"anonymous":false,"userid":"2083469","username":"Toddiloddi","revid":"685287867","comment":null,"timestamp":"2015-10-12T00:31:54Z"},"doi_title":"insights from lgi1 and caspr2 potassium channel complex autoantibody subtyping","doi_title_normalized":"insightsfromlgi1andcaspr2potassiumchannelcomplexautoantibodysubtyping","title_length":69,"levenshtein_distance":0,"score_similarity":0.0}}
{"doi":"10.1001/jamaneurol.2013.5993","field":"神経科学・行動科学","meta":{"pageid":"13033422","title":"Multiple sclerosis research","anonymous":true,"username":"79.153.180.74","type":"ip","revid":"591856524","comment":"Research in biomarkers","timestamp":"2014-01-22T11:38:38Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2013.5993","doi_suffix":"jamaneurol.2013.5993","pubmed":["24445558"],"pmc":["4000029"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2013.5993","doi_suffix":"jamaneurol.2013.5993","pubmed":["24445558"]},"meta":{"anonymous":true,"username":"79.153.180.74","revid":"591856524","comment":"Research in biomarkers","timestamp":"2014-01-22T11:38:38Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"vitamin d as an early predictor of multiple sclerosis activity and progression","doi_title_full_normalized":"vitamin d as an early predictor of multiple sclerosis activity and progression","doi_title_full_normalized_without_spc":"vitamindasanearlypredictorofmultiplesclerosisactivityandprogression","doi_title_first_words":"vitamin d as an early","doi_title_first_words_normalized":"vitamin d as an early","doi_title_first_words_nomralized_without_spc":"vitamindasanearly","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":true,"username":"79.153.180.74","revid":"591856524","comment":"Research in biomarkers","timestamp":"2014-01-22T11:38:38Z"}},"MethodC":{"cond_score":0.2,"wikitext":{"original":"<ref> ni en el bitcoind, et al. Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression, JAMA Neurol. 2014 Jan 20. doi: 10.1001/jamaneurol.2013.5993, PMID 24445558</ref>","input_parscit":"ni en el bitcoind, et al. Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression, JAMA Neurol. 2014 Jan 20. doi: 10.1001/jamaneurol.2013.5993, PMID 24445558","ref_title":"Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression, JAMA Neurol.","ref_title_normalized":"vitamindasanearlypredictorofmultiplesclerosisactivityandprogressionjamaneurol"},"meta":{"anonymous":true,"username":"79.153.180.74","revid":"591856524","comment":"Research in biomarkers","timestamp":"2014-01-22T11:38:38Z"},"doi_title":"vitamin d as an early predictor of multiple sclerosis activity and progression","doi_title_normalized":"vitamindasanearlypredictorofmultiplesclerosisactivityandprogression","title_length":77,"levenshtein_distance":10,"score_similarity":0.12987012987012986}}
{"doi":"10.1001/jamaneurol.2014.1205","field":"神経科学・行動科学","meta":{"pageid":"34225306","title":"IDH1","anonymous":false,"userid":"26248702","username":"Mbanting","type":"user","revid":"682578119","comment":"Added a section to Clinical Relevance about the mutation and it's implications for enzyme function and methylation.","timestamp":"2015-09-24T16:20:02Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2014.1205","doi_suffix":"jamaneurol.2014.1205","pubmed":["25155243"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2014.1205","doi_suffix":"jamaneurol.2014.1205","pubmed":["25155243"]},"meta":{"anonymous":false,"userid":"2428506","username":"Boghog","revid":"682593826","comment":"consistent citation formatting","timestamp":"2015-09-24T18:22:51Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"idhmutation in glioma","doi_title_full_normalized":"idhmutation in glioma","doi_title_full_normalized_without_spc":"idhmutationinglioma","doi_title_first_words":"idhmutation in glioma","doi_title_first_words_normalized":"idhmutation in glioma","doi_title_first_words_nomralized_without_spc":"idhmutationinglioma","trigger":{"doi_title_full":false,"doi_title_full_normalized":false,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":false,"doi_title_first_words_normalized":false,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":false,"userid":"26248702","username":"Mbanting","revid":"682578119","comment":"Added a section to Clinical Relevance about the mutation and it's implications for enzyme function and methylation.","timestamp":"2015-09-24T16:20:02Z"}},"MethodC":{"cond_score":0.2,"wikitext":{"original":"<ref name=IDH1-JAMA>{{cite journal|last1=Das|first1=Sunit|last2=Karamchandani|first2=Jason|title=IDH Mutation in Glioma|journal=JAMA Neurology|date=October 2014|volume=71|issue=10|page=1319-1325|accessdate=20 September 2015}}</ref>","ref_title":"IDH Mutation in Glioma","ref_title_normalized":"idhmutationinglioma"},"meta":{"anonymous":false,"userid":"26248702","username":"Mbanting","revid":"682578119","comment":"Added a section to Clinical Relevance about the mutation and it's implications for enzyme function and methylation.","timestamp":"2015-09-24T16:20:02Z"},"doi_title":"idhmutation in glioma","doi_title_normalized":"idhmutationinglioma","title_length":19,"levenshtein_distance":0,"score_similarity":0.0}}
{"doi":"10.1001/jamaneurol.2014.131","field":"神経科学・行動科学","meta":{"pageid":"11212543","title":"Ubiquinol","anonymous":false,"userid":"12640907","username":"Committed molecules","type":"user","revid":"614143611","comment":"Update of Neuronal health section with latest publication on Early Parkinson disease study and update of link","timestamp":"2014-06-23T21:03:56Z"},"MethodA":{"identifiers":{"doi":"10.1001/jamaneurol.2014.131","doi_suffix":"jamaneurol.2014.131","pubmed":["24664227"]},"matched_identifiers":{"doi":"10.1001/jamaneurol.2014.131","doi_suffix":"jamaneurol.2014.131","pubmed":["24664227"]},"meta":{"anonymous":false,"userid":"12640907","username":"Committed molecules","revid":"614143611","comment":"Update of Neuronal health section with latest publication on Early Parkinson disease study and update of link","timestamp":"2014-06-23T21:03:56Z"}},"MethodB":{"cond_first_words":5,"doi_title_full":"a randomized clinical trial of high-dosage coenzyme q10 in early parkinson disease","doi_title_full_normalized":"a randomized clinical trial of high dosage coenzyme q10 in early parkinson disease","doi_title_full_normalized_without_spc":"arandomizedclinicaltrialofhighdosagecoenzymeq10inearlyparkinsondisease","doi_title_first_words":"a randomized clinical trial of","doi_title_first_words_normalized":"a randomized clinical trial of","doi_title_first_words_nomralized_without_spc":"arandomizedclinicaltrialof","trigger":{"doi_title_full":true,"doi_title_full_normalized":true,"doi_title_full_normalized_without_spc":true,"doi_title_first_words":true,"doi_title_first_words_normalized":true,"doi_title_first_words_nomralized_without_spc":true},"meta":{"anonymous":false,"userid":"12640907","username":"Committed molecules","revid":"614143611","comment":"Update of Neuronal health section with latest publication on Early Parkinson disease study and update of link","timestamp":"2014-06-23T21:03:56Z"}},"MethodC":{"cond_score":0.2}}
